EQUILLIUM, INC. Debt Securities, Available-for-sale, Amortized Cost
EQUILLIUM, INC. (EQ) had Debt Securities, Available-for-sale, Amortized Cost of $4.49 million as of 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-03-25
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $4.49M.
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $10.42M.
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $22.25M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $20.72M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2024-12-31 | $4.49M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $10.42M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $22.25M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $20.72M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $17.63M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $11.94M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $22.78M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $37.48M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $12.01M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $19.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $34.04M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $42.81M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $30.40M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $13.54M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $24.12M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $53.21M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $58.17M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $41.24M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $18.41M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $26.87M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $39.88M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $34.51M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $34.20M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $40.16M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $37.40M 10-K · filed 2020-03-26 | $37.40M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |